Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001437749-26-004912 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
300
Total Value
$1,701.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | Feb 19, 2026 | Exercise/Conversion | 100 | $1.01 | $101.00 | 156,152 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Feb 19, 2026 | Sale | 100 | $16.00 | $1,600.00 | 156,052 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Feb 19, 2026 | Exercise/Conversion | 100 | $0.00 | $0.00 | 75,430 | Direct | โ | View Details |